REXAHN PHARMACEUTICALS, INC. (66) | Sales Agreements (1)

Recent Contracts

Capital on Demand Sales Agreement, dated March 11, 2021 between Ocuphire Pharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on March 11, 2021)